NEW Our free Dividend Tracker is live — see what your stocks pay you
Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.
Start Free »

Bruker Corporation BRKR | NASDAQ

$63.23 $1.29 | 2.08%
SIGNAL:Signal available — unlock to view |2026-09-23 |F&G 64 |RSI 57.3

Company Overview:

Market Cap: $9.63B
Trailing PE: N/A
FWD PE *: 27.9x
Payout Ratio (TTM): —
52-Week Range: $32.37 - $66.98

* Forward PE is based on street estimates.

10 Year BRKR Performance Metrics:

Total Return (with DRIP): 194.2% (11.39% CAGR)
Total Return (no DRIP): 190.8% (11.27% CAGR)
Share Price: 183.0% (10.96% CAGR)
Yield on Cost (with DRIP): 0.93%
Total Invested: $10,000
Total Value (with DRIP): $29,416
Total Return $ (with DRIP): $19,416
Dividend Increase: 25.0% (2.36% CAGR)
Dividend Yield (FWD): 0.32% ($0.20)
BRKR 10-yr Total Return ($10K invested)
1M 3M 6M YTD 1Y 3Y 5Y 10Y
BRKR Share Price
1M 3M 6M YTD 1Y 3Y 5Y 10Y All
BRKR Price CAGR:1Y: 81.54%2Y: -3.19%5Y: -4.16%10Y: 10.96%
BRKR Dividend Charts
BRKR - Dividends
BRKR Dividend CAGR:1Y: 0.00%2Y: 0.00%5Y: 4.56%10Y: 2.26%
BRKR - Dividend Payout Ratio
BRKR Dividend Payout Ratio CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
BRKR - Dividend to Free Cash Flow Ratio
BRKR Dividend to FCF Ratio CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)

BRKR Fundamentals: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

BRKR - Revenue
BRKR Revenue CAGR:1Y: 5.15%2Y: 2.33%5Y: 8.00%10Y: 8.48%
BRKR - Earnings Per Share (EPS)
BRKR EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
BRKR - Net Income
🔓 See the full chart40% off right now · 7-day free trial
BRKR Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
BRKR - EBITDA
🔓 See the full chart40% off right now · 7-day free trial
BRKR EBITDA CAGR:1Y: -76.07%2Y: -62.93%5Y: -31.12%10Y: -9.30%
BRKR - Free Cash Flow
🔓 See the full chart40% off right now · 7-day free trial
BRKR Free Cash Flow CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
BRKR - Free Cash Flow / Share
🔓 See the full chart40% off right now · 7-day free trial
BRKR Free Cash Flow / Share CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
BRKR - Operating Income
🔓 See the full chart40% off right now · 7-day free trial
BRKR Operating Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
BRKR - Gross Profit
🔓 See the full chart40% off right now · 7-day free trial
BRKR Gross Profit CAGR:1Y: 16.23%2Y: 3.35%5Y: 8.19%10Y: 9.36%
BRKR - Shares Outstanding
🔓 See the full chart40% off right now · 7-day free trial
BRKR Shares Outstanding CAGR:1Y: 0.33%2Y: 1.41%5Y: -0.09%10Y: -0.65%
BRKR - Share Buybacks
🔓 See the full chart40% off right now · 7-day free trial
BRKR Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
BRKR - Stock-Based Comp
🔓 See the full chart40% off right now · 7-day free trial
BRKR Stock-Based Comp CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
BRKR - Expenses
🔓 See the full chart40% off right now · 7-day free trial
BRKR Expenses CAGR:1Y: 35.21%2Y: 8.20%5Y: 4.97%10Y: 12.09%
BRKR - Revenue vs Net Income
🔓 See the full chart40% off right now · 7-day free trial
BRKR - EPS vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
BRKR - EPS vs PE Ratio
🔓 See the full chart40% off right now · 7-day free trial
BRKR - FCF vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
BRKR - FCF vs Stock Based Comp
🔓 See the full chart40% off right now · 7-day free trial
BRKR - Cash & Debt
🔓 See the full chart40% off right now · 7-day free trial
BRKR - Revenue by Segment
🔓 See the full chart40% off right now · 7-day free trial
BRKR Revenue CAGR:1Y: 5.15%2Y: 2.33%5Y: 8.00%10Y: 8.48%
BRKR - Revenue by Region
🔓 See the full chart40% off right now · 7-day free trial
BRKR Revenue CAGR:1Y: 5.15%2Y: 2.33%5Y: 8.00%10Y: 8.48%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

BRKR - REVENUE: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
BRKR Actual Revenue CAGR:1Y: 5.15%2Y: 2.33%5Y: 8.00%10Y: 8.48%
BRKR - EPS: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
BRKR Actual EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
BRKR - NET INCOME: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
BRKR Actual Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
BRKR - EBITDA: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
BRKR Actual EBITDA CAGR:1Y: -76.07%2Y: -62.93%5Y: -31.12%10Y: -9.30%

Ratios, Profit Margins & Return on Capital:

BRKR - Net Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
BRKR Net Profit Margin CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
BRKR - Gross Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
BRKR Gross Profit Margin CAGR:1Y: 10.54%2Y: 0.99%5Y: 0.18%10Y: 0.81%
BRKR - Price to Earnings
🔓 See the full chart40% off right now · 7-day free trial
BRKR Price to Earnings CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
BRKR - Price To Sales Ratio
🔓 See the full chart40% off right now · 7-day free trial
BRKR Price To Sales Ratio CAGR:1Y: 39.46%2Y: -2.43%5Y: -11.52%10Y: 1.02%
BRKR - Return on Capital Employed
🔓 See the full chart40% off right now · 7-day free trial
BRKR Return on Capital Employed CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
BRKR - Return on Invested Capital
🔓 See the full chart40% off right now · 7-day free trial
BRKR Return on Invested Capital CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Compare stocks side-by-side

BRKR Dividends Info:

Annual Dividend: $0.2
Forward Yield: 0.32%
Ex-Dividend Date: 2026-09-21
Lifetime Dividends / Share: $1.96

BRKR Dividend History: Dates, Payments & Yield list

Below is a schedule of all BRKR dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield

Ex-Date Payment Date Amount Yield Forward Yield Price on Ex-Date
09/21/202610/07/2026$0.0500.32%0.34%$59.67
06/22/202607/07/2026$0.0500.35%0.34%$58.25
03/23/202604/07/2026$0.0500.57%0.55%$36.67
12/08/202501/02/2026$0.0500.43%0.42%$48.11
09/23/202510/03/2025$0.0500.6%0.54%$36.98
06/16/202506/27/2025$0.0500.51%0.48%$41.80
03/17/202503/28/2025$0.0500.43%0.48%$42.08
12/02/202412/16/2024$0.0500.34%0.35%$57.18
08/30/202409/16/2024$0.0500.3%0.31%$65.28
05/31/202406/17/2024$0.0500.31%0.31%$64.85
06/03/202406/17/2024$0.0500.31%0.31%$64.85
02/29/202403/15/2024$0.0500.23%0.22%$92.10
11/30/202312/15/2023$0.0500.31%0.27%$73.36
08/31/202309/15/2023$0.0500.3%0.3%$66.43
05/31/202306/16/2023$0.0500.29%0.26%$75.48
02/28/202303/17/2023$0.0500.29%0.28%$72.18
11/30/202212/16/2022$0.0500.3%0.31%$64.41
08/31/202209/16/2022$0.0500.36%0.38%$52.88
05/31/202206/17/2022$0.0500.32%0.34%$59.28
02/28/202203/18/2022$0.0500.28%0.29%$68.64
11/30/202112/17/2021$0.0400.2%0.2%$78.55
08/31/202109/17/2021$0.0400.18%0.19%$83.35
05/28/202106/18/2021$0.0400.23%0.22%$72.29
03/04/202103/19/2021$0.0400.27%0.26%$60.69
11/30/202012/18/2020$0.0400.32%0.29%$55.48
08/31/202009/18/2020$0.0400.38%0.41%$38.63
05/29/202006/19/2020$0.0400.37%0.39%$41.09
03/06/202003/20/2020$0.0400.36%0.47%$34.37
11/29/201912/20/2019$0.0400.31%0.31%$51.61
08/30/201909/20/2019$0.0400.37%0.37%$43.54
05/31/201906/21/2019$0.0400.38%0.33%$48.76
03/04/201903/22/2019$0.0400.41%0.42%$38.10
11/30/201812/21/2018$0.0400.48%0.6%$26.50
08/31/201809/21/2018$0.0400.45%0.49%$32.87
06/01/201806/22/2018$0.0400.52%0.53%$30.01
03/05/201803/23/2018$0.0400.54%0.55%$29.12
12/01/201712/22/2017$0.0400.46%0.47%$34.08
08/31/201709/22/2017$0.0400.55%0.54%$29.36
06/01/201706/23/2017$0.0400.58%0.53%$29.98
03/06/201703/24/2017$0.0400.67%0.69%$23.19
12/01/201612/23/2016$0.0400.71%0.74%$21.53
09/01/201609/23/2016$0.0400.71%0.72%$22.37
06/02/201606/24/2016$0.0400.6%0.7%$22.90
03/02/201603/24/2016$0.0400.57%0.58%$27.43

Projected Future Returns & Dividends for BRKR

Based on past 10-year performance, here are BRKR growth metrics:

Share price CAGR of +10.96%
Dividend CAGR of +2.26%

Using BRKR CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

BRKR (DRIP)BRKR - No DRIP
Current Price$63.23$63.23
Start Shares158.15158.15
Start Value$10,000$10,000
  
After 10 years:
Final Share Count161.75158.15
Dividends Payment$0.06$0.06
Annual Dividends$40$40
Yield on cost0.40%0.40%
Share Price$178.96$178.96
Total Dividends$355$350
Final Value$28,948$28,654

Estimated Future Value + Dividends - BRKR

NOTE: Above numbers are our estimate based on BRKR's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)

Company Info

Bruker Corporation (BRKR) had its IPO on 2000-08-04, and is traded on NASDAQ stock exchange.

Bruker Corporation stands as a prominent global developer, manufacturer, and distributor of cutting-edge scientific instruments, alongside comprehensive analytical and diagnostic solutions. Its operations are structured across three distinct segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. The company's extensive portfolio for life sciences encompasses a variety of advanced tools, including single and multi-modality systems, sophisticated mass spectrometry platforms, and critical diagnostic solutions. These diagnostics feature the acclaimed MALDI Biotyper for swift pathogen identification, various molecular diagnostic kits (such as genotype and fluorotype offerings), DNA test strips, and fluorescence-based polymerase chain reaction (PCR) technology, notably including SARS-CoV-2 testing solutions for COVID-19 diagnosis and Fluorotyper-SARS-CoV-2 plus kits. Beyond life science, Bruker delivers a wide array of specialized instruments for research, analysis, and process control. This includes portable analytical and bioanalytical detection systems, a full range of X-ray instruments (from analytical tools for electron microscopes to handheld, portable, and mobile X-ray fluorescence spectrometry devices), and sophisticated atomic force microscopy (AFM) instrumentation for non-contact nanometer resolution topography. Furthermore, it supplies automated X-ray metrology, automated AFM defect-detection, and equipment for photomask repair and cleaning. The company also excels in advanced optical fluorescence microscopy and provides critical products and services supporting multi-omics research for drug and biomarker discovery. Within its energy sector, Bruker is a key provider of superconducting materials, particularly metallic low-temperature superconductors, and develops complex tools and devices utilizing these materials, alongside other high-technology tools like synchrotron and beamline instrumentation. Reflecting its commitment to innovation, Bruker Corporation collaborates with Newomics Inc. on an LC-MS platform specifically tailored for drug discovery applications. Established in 1991, the corporation maintains its headquarters in Billerica, Massachusetts.

BRKR website: https://www.bruker.com


Get Full Access to All Reports with DRIPCalc PRO

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)
Loading signals…

DCF Model — BRKR

Value from:
Pay up to today
—
vs current price $63.23
—
Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
YearFCFImplied price
Sensitivity — fair value: growth ↓ × target return →